These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31838901)

  • 21. Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.
    Yang X; Fan D; Troha AH; Ahn HM; Qian K; Liang B; Du Y; Fu H; Ivanov AA
    Bioorg Med Chem; 2021 Sep; 45():116324. PubMed ID: 34333394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of naphthyl-N-acylhydrazone p38α MAPK inhibitors with in vivo anti-inflammatory and anti-TNF-α activity.
    Freitas RHCN; Cordeiro NM; Carvalho PR; Alves MA; Guedes IA; Valerio TS; Dardenne LE; Lima LM; Barreiro EJ; Fernandes PD; Fraga CAM
    Chem Biol Drug Des; 2018 Feb; 91(2):391-397. PubMed ID: 28815968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.
    Butler MS; Roshan-Moniri M; Hsing M; Lau D; Kim A; Yen P; Mroczek M; Nouri M; Lien S; Axerio-Cilies P; Dalal K; Yau C; Ghaidi F; Guo Y; Yamazaki T; Lawn S; Gleave ME; Gregory-Evans CY; McIntosh LP; Cox ME; Rennie PS; Cherkasov A
    Oncotarget; 2017 Jun; 8(26):42438-42454. PubMed ID: 28465491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents.
    Debnath S; Kanakaraju M; Islam M; Yeeravalli R; Sen D; Das A
    Comput Biol Chem; 2019 Dec; 83():107156. PubMed ID: 31710991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking.
    Caporuscio F; Tinivella A; Restelli V; Semrau MS; Pinzi L; Storici P; Broggini M; Rastelli G
    Future Med Chem; 2018 Jul; 10(13):1545-1553. PubMed ID: 29766737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel glyceraldehyde-3-phosphate dehydrogenase inhibitor via docking-based virtual screening.
    Li T; Tan X; Yang R; Miao Y; Zhang M; Xi Y; Guo R; Zheng M; Li B
    Bioorg Chem; 2020 Mar; 96():103620. PubMed ID: 32028064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
    Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
    Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and molecular docking studies of new furochromone derivatives as p38α MAPK inhibitors targeting human breast cancer MCF-7 cells.
    Amin KM; Syam YM; Anwar MM; Ali HI; Abdel-Ghani TM; Serry AM
    Bioorg Med Chem; 2017 Apr; 25(8):2423-2436. PubMed ID: 28291685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of fragment screening methods on the p38α kinase: new methods, new insights.
    Pollack SJ; Beyer KS; Lock C; Müller I; Sheppard D; Lipkin M; Hardick D; Blurton P; Leonard PM; Hubbard PA; Todd D; Richardson CM; Ahrens T; Baader M; Hafenbradl DO; Hilyard K; Bürli RW
    J Comput Aided Mol Des; 2011 Jul; 25(7):677-87. PubMed ID: 21732248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel spiroindoline targets cell cycle and migration via modulation of microtubule cytoskeleton.
    Kumar N; Hati S; Munshi P; Sen S; Sehrawat S; Singh S
    Mol Cell Biochem; 2017 May; 429(1-2):11-21. PubMed ID: 28213771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of multi-targeted natural compounds for receptor tyrosine kinases inhibitors and biological evaluation on cancer cell lines, in silico and in vitro.
    Singh P; Bast F
    Med Oncol; 2015 Sep; 32(9):233. PubMed ID: 26298529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel androgen receptor antagonists: a hybrid approach of pharmacophore-based and docking-based virtual screening.
    Liu J; Liu B; Guo G; Jing Y; Zhao G
    Anticancer Drugs; 2015 Aug; 26(7):747-53. PubMed ID: 25933245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
    Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
    J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethyl 2-(benzylidene)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate analogues as a new scaffold for protein kinase casein kinase 2 inhibitor.
    Jin CH; Jun KY; Lee E; Kim S; Kwon Y; Kim K; Na Y
    Bioorg Med Chem; 2014 Sep; 22(17):4553-65. PubMed ID: 25131958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors.
    Astolfi A; Iraci N; Manfroni G; Barreca ML; Cecchetti V
    ChemMedChem; 2015 Jun; 10(6):957-69. PubMed ID: 26012502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a new bioactive molecule for neuroblastoma.
    Leitão A; Schramm A; Eggert A
    Chem Biol Drug Des; 2013 Aug; 82(2):233-41. PubMed ID: 23601248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics.
    Zhang W; Hu X; Chakravarty H; Yang Z; Tam KY
    ACS Comb Sci; 2018 Nov; 20(11):660-671. PubMed ID: 30350563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards the chemoinformatic-based identification of DNA methyltransferase inhibitors: 2D- and 3D-similarity profile of screening libraries.
    Yoo J; Medina-Franco JL
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):317-29. PubMed ID: 22734709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
    Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW
    BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.